Home > Specialists > Urology > Dr. Xiaojing Wang (王晓晶)
Specialty & Clinical Focus:
Dr. Xiaojing Wang is a urologist at Ruijin Hospital in Shanghai, with a clinical focus on minimally invasive laparoscopic and robotic surgery for bladder, kidney, prostate, upper urinary tract and adrenal tumors, including bladder-sparing treatment and urinary reconstruction.
Professional Title & Qualifications:
-
Associate Chief Physician
-
Medical Doctorate
Hospital & Department：
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine – Department of Urology
Shanghai International Medical Center (SIMC) – Department of Urology
(address: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, 200025)
(address: No. 4358 Kangxin Road, Pudong New District , Shanghai, 201315)
Dr. Xiaojing Wang (王晓晶) - Urologist
Personal Biography
Dr. Xiaojing Wang is an Associate Chief Physician in the Department of Urology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. He holds a medical doctorate, graduated from Shanghai Jiao Tong University School of Medicine in 2008, and has worked at Ruijin Hospital for nearly two decades. He also served as a visiting scholar at the University of New South Wales in Australia and is involved in standardized surgical residency training at Ruijin Hospital.
Dr. Wang performs approximately 500 minimally invasive laparoscopic and robotic urological procedures each year. His clinical work covers bladder, kidney, renal pelvis and ureter, prostate and adrenal tumors, as well as urinary stones. He has been involved in the care of more than 3,000 patients with bladder cancer, with particular experience in bladder-sparing approaches, radical cystectomy, orthotopic neobladder and ileal conduit reconstruction. His research focuses on urological tumors, especially bladder cancer. His recognitions include Ruijin Hospital’s “Advanced Teacher” and “Advanced Individual” awards in 2018 and first place in the 2019 National Young and Middle-aged Urologists Clinical Skills Competition.
Why Choose Dr. Xiaojing Wang (Core Benefits for International Patients)
International patients considering complex urological care may value Dr. Xiaojing Wang’s combination of nearly two decades at Ruijin Hospital, overseas academic experience at the University of New South Wales, and a focused practice in minimally invasive and robotic urological surgery. His work spans bladder, kidney and prostate cancers, with particular depth in individualized bladder cancer management, bladder-sparing strategies and urinary reconstruction after cystectomy.
For international patients seeking a remote specialist review or considering medical travel to Shanghai, a well-organized record set—including pathology, imaging, prior treatment history, current test results and a focused question list—can support a more efficient case discussion. Dr. Wang’s review can help clarify the relevant treatment pathways and whether further in-person evaluation at Ruijin Hospital should be considered, giving patients a clearer basis for planning their next step.
Pre-Travel Case Review & Specialist Liaison
Before travelling to Shanghai for complex urological care, international patients can request MedBridgeNZ coordination for a pre-travel specialist review with Dr. Xiaojing Wang. We help organize the medical record set, coordinate translation where needed, arrange client-authorized document transfer and communicate the patient’s key questions to Ruijin Hospital. Dr. Wang or the designated hospital team will review the submitted records and provide a specialist opinion, recommendations and responses to the patient’s questions through the arranged review pathway.
After the review, MedBridgeNZ can assist with appointment request communication, medical invitation or visa-document coordination support, travel planning, accommodation arrangements and non-clinical bilingual administrative support in Shanghai. This gives patients a more structured basis for deciding whether to proceed with an in-person pathway before committing to international travel.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Xiaojing Wang
Areas of Expertise
Proficient in various minimally invasive surgeries (laparoscopic/robotic) for urological tumors, with a special focus on individualized and precise treatment for bladder cancer. This includes transurethral resection/laser therapy and BCG perfusion management for superficial bladder cancer, comprehensive bladder-sparing therapy for invasive bladder cancer, various high-difficulty urinary diversion and reconstruction surgeries (orthotopic neobladder, ileal conduit, etc.) after cystectomy, and comprehensive treatment including chemotherapy, immunotherapy, and targeted therapy for advanced bladder cancer.
Skilled in nerve-sparing and continence-preserving radical prostatectomy, nephron-sparing surgery for complex renal tumors, resection of giant adrenal tumors, and single-position totally laparoscopic radical nephroureterectomy.
Experienced in minimally invasive surgical treatment for benign diseases such as urinary stones, benign prostatic hyperplasia, renal cysts, hydroceles, and the diagnosis and treatment of andrological diseases like varicocele.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
2,700 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Graduated from Shanghai Jiao Tong University School of Medicine in 2008 and has been working at Ruijin Hospital since then for nearly 20 years.
Education & Training
Graduated from Shanghai Jiao Tong University School of Medicine in 2008.
Visiting scholar at the University of New South Wales, Australia.
Awards & Honors
Awarded the titles of “Advanced Teacher” and “Advanced Individual” at Ruijin Hospital in 2018.
Champion, National Young and Middle-aged Urologists Clinical Skills Competition, 2019.
Academic & Professional Memberships
Research & Publications
Dr. Wang's research primarily focuses on the clinical and basic aspects of urological tumors, especially bladder cancer.
Publications: He has published over 10 articles as the first or corresponding author, including 8 SCI papers in international urology academic journals such as the Journal of Urology and BJU International.
Research Funding: He has led 3 provincial and ministerial-level projects (Ministry of Education Industry-Academia-Education Fund; Shanghai Jiao Tong University “Star of Jiao Tong” Medical-Engineering Interdisciplinary Project; Shanghai Higher Education Excellent Young Teacher Selection and Cultivation Special Research Fund). He has also participated in one National Natural Science Foundation of China project.
Book Contributions: He has co-authored 4 monographs: “Robotic Urologic Surgery,” “Modern Adrenal Surgery Diagnosis and Treatment,” “Minimally Invasive Urologic Surgery,” and “Prostate Diseases.” He also co-translated the 11th edition of “Campbell-Walsh Urology,” a foundational text in the field of urology.
Selected Peer-Reviewed Publications
Ma Z, Wang X, et al. Innovative surgical management of ileal neobladder fistula after radical cystectomy. Front Oncol. 2025;15:1635458. PMID: 41132725
Zhu Z, Wang X, et al. Preoperative predictors of early death risk in bladder cancer patients treated with robot-assisted radical cystectomy. Cancer Med. 2019;8(7):3447–3452. PMID: 31091022
Wang X, et al. TRIM38 triggers the ubiquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer. J Transl Med. 2021;19(1):508. PMID: 34906161
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I find out whether Dr. Wang’s expertise is relevant to my diagnosis?
You can request a pre-travel specialist-review pathway through MedBridgeNZ and provide your pathology, imaging, prior treatment records, current test results and key questions. We coordinate record preparation, translation where needed, client-authorized document transfer and communication with Ruijin Hospital. Dr. Wang or the designated hospital team will review the submitted materials and provide a specialist opinion, recommendations and responses to your questions, particularly for complex bladder, kidney, prostate or upper urinary tract conditions. This can help you understand the proposed clinical direction before deciding whether to travel to Shanghai.
If an in-person pathway is recommended, how can MedBridgeNZ help with Ruijin Hospital and travel to China?
After the specialist review, MedBridgeNZ can coordinate appointment requests and scheduling communication with Ruijin Hospital. We can also assist with medical invitation or visa-document coordination support, travel planning, accommodation arrangements, translation coordination and non-clinical bilingual administrative support during the hospital visit. Appointment dates and procedural details are confirmed through the hospital team, while MedBridgeNZ helps keep the administrative and travel process organized for the patient and accompanying family members.
Which minimally invasive and robotic urology procedures are within Dr. Wang’s clinical focus?
Dr. Wang’s clinical focus includes minimally invasive laparoscopic and robotic surgery for urological tumors. His documented areas of expertise include transurethral resection or laser treatment for superficial bladder cancer, bladder-sparing approaches, radical cystectomy with urinary diversion or reconstruction such as orthotopic neobladder and ileal conduit, nerve-sparing and continence-preserving prostatectomy, nephron-sparing surgery for complex renal tumors, adrenal tumor surgery and laparoscopic radical nephroureterectomy. A remote specialist review can help clarify which options are relevant to an individual case based on the submitted records.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We assist with medical-record preparation, translation coordination, client-authorized document transfer, appointment request communication, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment. Hospital, specialist and other third-party medical or travel charges are separate from MedBridgeNZ coordination fees unless expressly stated in writing.